KAREN BOYD: Open Payments
NPI 1386642791 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 85 payments from 9 companies in 2025. Trend: 2023 $742 · 2024 $1,083 · 2025 $1,400
Food & beverage: $1,250Education: $150
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 45 | $746 |
| Otsuka America Pharmaceutical, Inc. | 15 | $155 |
| Lundbeck LLC | 8 | $147 |
| Janssen Pharmaceuticals, Inc | 11 | $138 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| ABBVIE INC. | 2 | $47 |
| Alkermes, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: INGREZZA, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, VRAYLAR, ARISTADA, Qelbree, FANAPT.
Industry payments across MI — which companies pay providers there.
